Leading Dermatologist Doing His Part to Warn Consumers
OMAHA, Neb., Dec. 12 /PRNewswire/ -- Lipodissolve, a treatment for
unwanted fat, has been in the news for the past several years with significant
controversy about its effectiveness and safety. Now, Fig, the parent company
for up to 18 facilities around the country that offer this treatment and
defender of this procedure, has closed its stores and is considering declaring
bankruptcy. This is in addition to a longtime 'unsatisfactory' rating by the
St. Louis Better Business Bureau, with 102 complaints over a year's period.
Despite the closure of this company, there are many companies still
selling the non FDA approved substance, PC/DC, which is used for this
procedure. Joel Schlessinger, M.D., Board-Certified Dermatologist and
Board-Certified General Cosmetic Surgeon and immediate past-president of the
American Society of Cosmetic Dermatology and Aesthetic Surgery (ASCDAS), has
been involved in spotlighting the dangers of treatment. He is also involved
in efforts to stop this treatment from being performed in his state, Nebraska.
Just Monday, December 10th, Kansas enacted stricter restrictions on this
procedure.
"It doesn't surprise me that Fig closed down -- the handwriting was on the
wall when they received the unsatisfactory rating from the BBB. While I've
been working on the Lipodissolve issue, many people have sustained harm from
this unapproved procedure. Now, countless people have lost their money
without any recourse due to the financial uncertainty of this company," says
Schlessinger.
"Patient safety shouldn't be put in jeopardy for the sake of making a
profit," said Joel Schlessinger M.D., founder of LovelySkin.com. "I've seen
half a dozen cases of patients who received treatments and then had pain,
swelling, bruising, bloating in the treatment areas, irregular dimpling and
divots in the skin. Hopefully, this closure will stop some of this from
happening."
Dr. Schlessinger is available for comment on Lipodissolve and its lack of
safety. Interviews with Dr. Schlessinger are available and interested media
may contact the company at 772-633-8337.
About Dr. Schlessinger
Joel Schlessinger M.D., board-certified dermatologist and general cosmetic
surgeon, is the immediate past-president of ASCDAS and the Nebraska
Dermatology Society. He continues to work with the FDA and the Nebraska State
Board of Healing Arts to regulate Lipodissolve.
Available Topic Expert(s): For information on the listed expert(s), click
appropriate link.
Joel Schlessinger, MD
http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=35185
SOURCE Joel Schlessinger M.D.
Joel Schlessinger M.D., +1-772-633-8337
